Articles tagged "Kidney transplantation"

2022 American Transplant Congress
Evaluation of Renal Function After Donation in Living Marginal Kidney Donor
S. Harada¹, H. Sasaki², Y. Takada², D. Takamoto², T. Hirano², T. Kan¹, Y. Yamagata¹, H. Harada², K. Minami¹, K. Moriya¹, H. Tanaka¹
¹Urology, Sapporo City General Hospital, Sapporo, Japan, ²Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan
*Purpose: Chronic kidney-donor shortage is major concern in Japan where more than 90% of recipients received kidneys from living donor as kidney transplantation from deceased…
2022 American Transplant Congress
Safety and Efficacy of Darbepoetin Alfa Dosing Strategies in Renal Transplant Recipients
J. A. Solis, A. Dao, T. Sam, T. Ma, A. F. Yango, B. V. Fischbach, N. Wilson
Baylor University Medical Center, Dallas, TX
*Purpose: Post-transplant anemia (PTA) is a common phenomenon in renal transplant recipients (RTR). There are currently no consensus guidelines for PTA, however patients are commonly…
2022 American Transplant Congress
A Nationwide, Multi-Center Survey of Lipid Management Strategies in Kidney Transplant Recipients
J. Pandav, R. Saranu, S. Muhsin, Z. Solhjou, J. Y. Choi, S. Gabardi, A. Chandraker
Renal division, Brigham and Women's Hospital, Boston, MA
*Purpose: KDIGO 2013 guidelines for the management of lipid transplant recommend the use of statins in all kidney transplant recipients (KTRs), but with weak evidence…
2022 American Transplant Congress
The Impact of Obesity on Delayed Graft Function
B. Shi¹, T. Ying², J. Xu¹, J. M. Laurence¹, S. Chadban¹
¹Royal Prince Alfred Hospital, Camperdown, Australia, ²University of Sydney, Camperdown, Australia
*Purpose: Obesity is increasingly prevalent among candidates for kidney transplantation. Outcomes for obese patients remain uncertain, as existing studies have shown conflicting short and longer-term…
2022 American Transplant Congress
The Role Of Gut Microbiome In Optimum Dose Selection Of Tacrolimus For Kidney Transplant Recipients
M. Nayebpour¹, N. Koizumi¹, J. Melancon²
¹George Mason University, Arlington, VA, ²George Washington University Hospital, Washington, DC
*Purpose: This study aims to validate and apply a personalized optimal dose selection model for Tacrolimus (Tac) for kidney transplant recipients at the George Washington…
2022 American Transplant Congress
Do Early Trends of Donor-Derived Cell Free DNA Predict Long Term Kidney Allograft Outcomes?
S. Park¹, K. Guo², L. Zhao², C. Rebello², J. Friedewald²
¹Transplant Nephrology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) has been studied and established for acute rejection detection but the impact of early dd-cfDNA changes on graft outcomes has…
2022 American Transplant Congress
Transplant Centers That Assess Frailty as Part of Clinical Practice Have Better Outcomes
X. Chen¹, Y. Liu¹, V. Thompson¹, N. M. Chu¹, E. A. King¹, J. D. Walston², J. A. Kobashigawa³, D. M. Dadhania⁴, D. L. Segev¹, M. A. McAdams-DeMarco¹
¹Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, ³Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, ⁴Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, NY
*Purpose: Frailty predicts adverse post-kidney transplant (KT) outcomes, yet impacts of frailty assessments on center-level outcomes remain unclear. We tested whether transplant centers assessing frailty…
2022 American Transplant Congress
Cold Ischemia Time is More Critical for Older Donor Kidney Survival: A Machine Learning Approach
J. Kim, J. Ahn, A. Massie, D. Segev, S. Bae
Johns Hopkins, Baltimore, MD
*Purpose: Increasing utilization of kidneys from older donors is a potential solution to mitigate the organ shortage. However, older donor age is a risk factor…
2022 American Transplant Congress
Immunogenicity of a 3rd Dose of Mrna Covid-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond to 2 Prior Doses
W. Werbel¹, A. Karaba¹, T. Chiang¹, T. Liang¹, A. Massie¹, M. Bettinotti¹, W. Clarke¹, N. Watson², A. Tobian¹, C. Durand¹, N. Bridges², D. Rostrosen², C. Larsen³, P. Heeger⁴, D. Segev¹
¹Johns Hopkins, Baltimore, MD, ²NIAID, Bethesda, MD, ³Emory University, Atlanta, GA, ⁴Mt. Sinai School of Medicine, New York, NY
*Purpose: Kidney transplant recipients (KTRs) have diminished immune response and protection after 2-dose mRNA COVID-19 vaccination. It is unknown if additional doses improve neutralization of…
2022 American Transplant Congress
Improving Efficiency in Kidney Distribution: A Comparison of UNet Deceased Donor Criteria to Actual Kidney Acceptance Practices
L. B. Zeiser, J. Ruck, D. Segev, A. Massie
Johns Hopkins University, Baltimore, MD
*Purpose: Efficient utilization of UNet deceased-donor criteria could help streamline kidney allocation by reducing the number of unwanted offers made to transplant centers. We compared…